TD Cowen analyst Tyler Van Buren maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) yesterday. The company’s shares ...

Intel has posted several quarters of market share losses in data centers and PCs, as well as billion-dollar losses in its ...

In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of ...

Primo Brands Corporation (NYSE: PRMB) ("Primo Brands" or the "Company") today announced that one of its stockholders (the ...